Fortunately they have no sway over the FDA. The be
Post# of 72440
We need one thing for IPIX to survive in a manner that preserves current shareholder stakes:
Secure a reasonable deal or partnership on one of the drugs in our portfolio.
Good news out of EOP2 greatly increases the likelihood of securing that deal.
Go IPIX!